Name: MDV 3100
Descriptions:
Product Number LS00074
CAS Number 915087-33-1
Product Name MDV 3100
Molecular Formula C21H16F4N4O2S
Formula Weight 464.44
http://www.lakesyn.com/html/e_747.html
For price inquiry, please send us email: sales@lakesyn.com
Enzalutamide (marketed as Xtandi and formerly known as MDV3100) is an androgen receptor antagonist drug developed by the pharmaceutical company Medivation for the treatment of metastatic castration-resistant prostate cancer.Medivation has reported up to an 89% decrease in prostate specific antigen serum levels after a month of taking the medicine. Early preclinical studies also suggest that enzalutamide inhibits breast cancer cell growth. In August of 2012, the U.S. Food and Drug Administration approved enzalutamide for the treatment of castration-resistant prostate cancer.
No comments:
Post a Comment